» Authors » Ana Teresa Timoteo

Ana Teresa Timoteo

Explore the profile of Ana Teresa Timoteo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 124
Citations 296
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Teixeira A, Barbas de Albuquerque F, Pereira-da-Silva T, Goncalves A, Moreira R, Timoteo A, et al.
Rev Port Cardiol . 2025 Mar; PMID: 40058409
Introduction And Objectives: Levosimendan infusion in the outpatient setting improves the clinical status of heart failure (HF) patients, although its hemodynamic effects are not entirely known. Remote monitoring using the...
2.
Jacinto S, Teixeira A, Goncalves A, Moreira R, Pereira da Silva T, Timoteo A, et al.
JACC Case Rep . 2025 Mar; 30(5):103090. PMID: 40054914
Background: Baroreflex activation therapy (BAT) is a novel treatment for heart failure with reduced ejection fraction (HFrEF) in patients who remain symptomatic despite optimal medical therapy (OMT) and who are...
3.
Trabulo M, Timoteo A
Rev Port Cardiol . 2025 Jan; 44(3):177-178. PMID: 39864737
No abstract available.
4.
Lacerda Teixeira B, Albuquerque F, Santos R, Ferreira A, Carvalheiro R, Reis J, et al.
Cardiovasc Ultrasound . 2025 Jan; 22(1):16. PMID: 39748402
Background: Right ventricular myocardial work (RVMW) assessed by transthoracic echocardiography allows to study the right ventricular (RV) function using RV pressure-strain loops. The assessment of these novel indexes of RVMW...
5.
Barbas de Albuquerque F, Teixeira R, Pereira-da-Silva T, Ferreira V, Valentim Goncalves A, Moreira R, et al.
Rev Port Cardiol . 2024 Aug; 44(1):1-8. PMID: 39216531
Introduction And Objectives: Left ventricular global longitudinal strain (LVGLS) is an indicator of myocardial function in patients with heart failure with reduced ejection fraction (HFrEF) and preserved ejection fraction (HFpEF)....
6.
Barison A, Timoteo A, Liga R, Borodzicz-Jazdzyk S, El Messaoudi S, Luong C, et al.
Eur Heart J Imaging Methods Pract . 2024 Jul; 2(1):qyae029. PMID: 39045198
In 2023, cardiovascular imaging has made significant advancements, in terms of technology, pathophysiology, and clinical application. In this review, the most recent research findings in the field of cardiovascular imaging...
7.
Abreu A, Dores H, Goncalves L, Franco F, Silveira C, Proenca G, et al.
Rev Port Cardiol . 2024 Jul; 43(11):633-641. PMID: 38972451
Atherosclerotic cardiovascular disease (ASCVD) remains the major cause of premature death and disability; effective cardiovascular (CV) risk prevention is fundamental. The World Heart Federation (WHF) Cholesterol Roadmap provides a framework...
8.
Timoteo A, Barbas Albuquerque F, Lacerda Teixeira B
Int J Cardiol . 2024 Jun; 412:132303. PMID: 38944349
Heart failure is an important cause of mortality and morbidity worldwide. Heart failure with preserved ejection fraction (HFpEF) incidence and prevalence is increasing, and the phenotype associated with obesity is...
9.
Timoteo A
Int J Cardiol . 2024 Jun; 411:132282. PMID: 38901569
No abstract available.
10.
Timoteo A
Arq Bras Cardiol . 2024 Jun; 121(5):e20240119. PMID: 38896586
No abstract available.